James R. Bell

James R. Bell

Auto-generated profile, based on publicly available information

James R. Bell

University of Melbourne

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023 in Cells
Verified
Journal Article
Open access
PDF file
SDSanela Dozic
Sanela Dozic
EHErin J. Howden
Erin J. Howden
JBJames R. Bell
James R. Bell
KMKim Mellor
Kim Mellor
LDLea M. D. Delbridge
Lea M. D. Delbridge
KWKate Weeks
Kate Weeks
Anthracyclines such as doxorubicin are widely used chemotherapy drugs. A common side effect of anthracycline therapy is cardiotoxicity, which can compromise heart function and lead to dilated cardiomyopathy and heart failure. Dexrazoxane and heart failure medications (i.e., beta blockers and drugs targeting the renin–angiotensin system) are prescribed for the primary prevention of cancer therapy-related cardiotoxicity and for the management of cardiac dysfunction and symptoms if they arise during chemotherapy. However, there is a clear need for new therapies to combat the cardiotoxic effects of cancer drugs. Exercise is a cardioprotective stimulus that has recently been shown to improve heart function and prevent functional disability in breast cancer patients undergoing anthracycline chemotherapy. Evidence from preclinical studies supports the use of exercise training to prevent or attenuate the damaging effects of anthracyclines on the cardiovascular system. In this review, we summarise findings from experimental models which provide insight into cellular mechanisms by which exercise may protect the heart from anthracycline-mediated damage, and identify knowledge gaps that require further investigation. Improved understanding of the mechanisms by which exercise protects the heart from anthracyclines may lead to the development of novel therapies to treat cancer therapy-related cardiotoxicity.

1 January 2002 in Clinical Radiology
Verified
Journal Article
Closed access
GBGuy J.C Burkill
Guy J.C Burkill
JBJames R.G Bell
James R.G Bell
RCRoger J.S Chinn
Roger J.S Chinn
JHJeremiah C Healy
Jeremiah C Healy
CCChristine Costello
Christine Costello
SPSimon P.G Padley
Simon P.G Padley

1 March 2024 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
JJJohannes V. Janssens
Johannes V. Janssens
ARAntonia J. A. Raaijmakers
Antonia J. A. Raaijmakers
KWKate Weeks
Kate Weeks
JBJames R. Bell
James R. Bell
KMKim Mellor
Kim Mellor
LDLea M. D. Delbridge
Lea M. D. Delbridge
The impaired ability of the heart to relax and stretch to accommodate venous return is generally understood to represent a state of “diastolic dysfunction” and often described using the all-purpose noun “stiffness.” Despite the now common qualitative usage of this term in fields of cardiac patho/physiology, the specific quantitative concept of stiffness as a molecular and biophysical entity with real practical interpretation in healthy and diseased hearts is sometimes obscure. The focus of this review is to characterize the concept of cardiomyocyte stiffness and to develop interpretation of “stiffness” attributes at the cellular and molecular levels. Here, we consider “stiffness”-related terminology interpretation and make links between cardiomyocyte stiffness and aspects of functional and structural cardiac performance. We discuss cross bridge-derived stiffness sources, considering the contributions of diastolic myofilament activation and impaired relaxation. This includes commentary relating to the role of cardiomyocyte Ca2+ flux and Ca2+ levels in diastole, the troponin-tropomyosin complex role as a Ca2+ effector in diastole, the myosin ADP dissociation rate as a modulator of cross bridge attachment and regulation of cross-bridge attachment by myosin binding protein C. We also discuss non-cross bridge-derived stiffness sources, including the titin sarcomeric spring protein, microtubule and intermediate filaments, and cytoskeletal extracellular matrix interactions. As the prevalence of conditions involving diastolic heart failure has escalated, a more sophisticated understanding of the molecular, cellular, and tissue determinants of cardiomyocyte stiffness offers potential to develop imaging and molecular intervention tools.

20 March 2013 in Applied Health Economics and Health Policy
Verified
Journal Article
Closed access
PDF file
MGManuel Gomes
Manuel Gomes
RARobert W Aldridge
Robert W Aldridge
PWPeter Wylie
Peter Wylie
JBJames Bell
James Bell
OEOwen Epstein
Owen Epstein

3 October 2023 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
SWSimon P. Wells
Simon P. Wells
ARAntonia J.A. Raaijmakers
Antonia J.A. Raaijmakers
CCClaire L. Curl
Claire L. Curl
COChristopher O’sHea
Christopher O’sHea
SHSarah Hayes
Sarah Hayes
JBJames R. Bell
James R. Bell
Transmural action potential duration differences and transmural conduction gradients aid the synchronization of left ventricular repolarization, reducing vulnerability to transmural reentry and arrhythmias. A high-fat diet and the associated accumulation of pericardial adipose tissue are linked with conduction slowing and greater arrhythmia vulnerability. It is predicted that cardiac adiposity may more readily influence epicardial conduction (versus endocardial) and disrupt normal transmural activation/repolarization gradients. The aim of this investigation was to determine whether transmural conduction gradients are modified in a rat model of pericardial adiposity. Adult Sprague-Dawley rats were fed control/high-fat diets for 15 wk. Left ventricular 300 µm tangential slices were generated from the endocardium to the epicardium, and conduction was mapped using microelectrode arrays. Slices were then histologically processed to assess fibrosis and cardiomyocyte lipid status. Conduction velocity was significantly greater in epicardial versus endocardial slices in control rats, supporting the concept of a transmural conduction gradient. High-fat diet feeding increased pericardial adiposity and abolished the transmural conduction gradient. Slowed epicardial conduction in epicardial slices strongly correlated with an increase in cardiomyocyte lipid content, but not fibrosis. The positive transmural conduction gradient reported here represents a physiological property of the ventricular activation sequence that likely protects against reentry. The absence of this gradient, secondary to conduction slowing and cardiomyocyte lipid accumulation, specifically in the epicardium, indicates a novel mechanism by which pericardial adiposity may exacerbate ventricular arrhythmias.

20 June 2024 in Journal of Molecular and Cellular Cardiology Plus
Verified
Journal Article
Open access
SWSimon P. Wells
Simon P. Wells
COChristopher O'SHea
Christopher O'SHea
SHSarah Hayes
Sarah Hayes
KWKate L. Weeks
Kate L. Weeks
PKPaulus Kirchhof
Paulus Kirchhof
JBJames R. Bell
James R. Bell
The electrophysiological properties of the hearts of women and men are different. These differences are at least partly mediated by the actions of circulating estrogens and androgens on the cardiomyocytes. Experimentally, much of our understanding in this field is based on studies focusing on ventricular tissue, with considerably less known in the context of atrial electrophysiology. The aim of this investigation was to compare the electrophysiological properties of male and female atria and assess responses to acute sex steroid exposure. Age-matched adult male and female C57BL/6 mice were anesthetized (4 % isoflurane) and left atria isolated. Atria were loaded with Di-4-ANEPPS voltage sensitive dye and optical mapping performed to assess action potential duration (APD; at 10 %, 20 %, 30 %, 50 %, and 70 % repolarization) and conduction velocity in the presence of 1 nM and 100 nM 17β-estradiol or testosterone. Male and female left atria demonstrated similar baseline action potential duration and conduction velocity, with significantly greater APD70 spatial heterogeneity evident in females. 17β-estradiol prolonged action potential duration in both sexes – an effect that was augmented in females. Atrial conduction was slowed in the presence of 100 nM 17β-estradiol in both males and females. Testosterone prolonged action potential duration in males only and did not modulate conduction velocity in either sex. This study provides novel insights into male and female atrial electrophysiology and its regulation by sex steroids. As systemic sex steroid levels change and intra-cardiac estrogen synthesis capacity increases with aging, these actions may have an increasingly important role in determining atrial arrhythmia vulnerability.